title: Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease.
abstract: An improvement in myocardial longitudinal systolic velocities, assessed by pulsed-wave tissue Doppler imaging during low-dose dobutamine infusion, was observed at 6-month follow-up after 6 months of treatment with atorvastatin. Our findings indicate a favorable effect of atorvastatin on contractile reserve, possibly through an enhancement of flow-dependent coronary dilatation during stress.
authors.affiliation: Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Manolis
authors.initials: M
authors.lastname: Bountioukos
authors.forename: Vittoria
authors.initials: V
authors.lastname: Rizzello
authors.forename: Boudewijn J
authors.initials: BJ
authors.lastname: Krenning
authors.forename: Jeroen J
authors.initials: JJ
authors.lastname: Bax
authors.forename: Miklos D
authors.initials: MD
authors.lastname: Kertai
authors.forename: Eleni C
authors.initials: EC
authors.lastname: Vourvouri
authors.forename: Arend F L
authors.initials: AF
authors.lastname: Schinkel
authors.forename: Elena
authors.initials: E
authors.lastname: Biagini
authors.forename: Eric
authors.initials: E
authors.lastname: Boersma
authors.forename: Jos R T C
authors.initials: JR
authors.lastname: Roelandt
authors.forename: Don
authors.initials: D
authors.lastname: Poldermans
mesh_terms: D000368:Aged; D000069059:Atorvastatin; D001783:Blood Flow Velocity / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D003971:Diastole / Q000187:drug effects; D018752:Diet, Fat-Restricted; D004280:Dobutamine; D015150:Echocardiography, Doppler / Q000295:instrumentation / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000097:blood / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects*; D011758:Pyrroles / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects; D013599:Systole / Q000187:drug effects; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
chemical_list: D002316:Cardiotonic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D014280:Triglycerides; D004280:Dobutamine; D000069059:Atorvastatin